# MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2

> **NCT05691608** · NA · RECRUITING · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 1800 (estimated)

## Conditions studied

- Solid Tumor
- Leukemia

## Interventions

- **BIOLOGICAL:** Solid tumor and CT DNA

## Key facts

- **NCT ID:** NCT05691608
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-09
- **Primary completion:** 2030-09-09
- **Final completion:** 2030-09-09
- **Target enrollment:** 1800 (ESTIMATED)
- **Last updated:** 2025-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05691608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05691608, "MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05691608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*